ArticleFrontiers in immunology2026

Pre-treatment T cell features and immune-milieu characteristics shape treatment-induced exhaustion and resistance to Blinatumomab in B-cell acute lymphoblastic leukemia.

Francesco Corrado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.